Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

US Interior Secretary Doug Burgum Talks US Energy Production
14:53

Nobel Laureate & CUNY Economics Professor Paul Krugman Talks Powell Investigation
06:04

Burlington CEO Michael O'Sullivan Talks Growth, Consumer Sentiment
10:04